Statistical fundamentals on cancer research for clinicians: Working with your statisticians
- PMID: 33532634
- PMCID: PMC7829109
- DOI: 10.1016/j.ctro.2021.01.006
Statistical fundamentals on cancer research for clinicians: Working with your statisticians
Abstract
Purpose: To facilitate understanding statistical principles and methods for clinicians involved in cancer research.
Methods: An overview of study design is provided on cancer research for both observational and clinical trials addressing study objectives and endpoints, superiority tests, non-inferiority and equivalence design, and sample size calculation. The principles of statistical models and tests including contemporary standard methods of analysis and evaluation are discussed. Finally, some statistical pitfalls frequently evident in clinical and translational studies in cancer are discussed.
Results: We emphasize the practical aspects of study design (superiority vs non-inferiority vs equivalence study) and assumptions underpinning power calculations and sample size estimation. The differences between relative risk, odds ratio, and hazard ratio, understanding outcome endpoints, purposes of interim analysis, and statistical modeling to minimize confounding effects and bias are also discussed.
Conclusion: Proper design and correctly constructed statistical models are critical for the success of cancer research studies. Most statistical inaccuracies can be minimized by following essential statistical principles and guidelines to improve quality in research studies.
Keywords: Cancer; Clinical research; Data analysis; Statistical models; Statistics; Study design.
© 2021 The Author(s).
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
References
-
- Sacca L. The uncontrolled clinical trial: scientific, ethical, and practical reasons for being. Intern Emerg Med. 2010;5(3):201–204. - PubMed
-
- Verweij J., Hendriks H.R., Zwierzina H. Cancer drug development F. Innovation in oncology clinical trial design. Cancer Treat Rev. 2019;74:15–20. - PubMed
-
- Sherman R.E., Anderson S.A., Dal Pan G.J. Real-world evidence – What is it and what can it tell us? N Engl J Med. 2016;375(23):2293–2297. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
